Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice.
about
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsCurcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulationMiltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical StudySimultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral MalariaNanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy.Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Formation of curcumin nanoparticles via solution-enhanced dispersion by supercritical CO2.Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.Therapeutic Applications of Curcumin NanoformulationsShort peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria.Treatment of Plasmodium chabaudi Parasites with Curcumin in Combination with Antimalarial Drugs: Drug Interactions and Implications on the Ubiquitin/Proteasome System.Advances in nanotechnology-based delivery systems for curcumin.Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.Antiparasitic and immunomodulatory potential of oral nanocapsules encapsulated lactoferrin protein against Plasmodium berghei.Nanotechnology-applied curcumin for different diseases therapy.Editorial: Natural Products in Oral HealthAnti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.Nanocurcumin: a novel antifilarial agent with DNA topoisomerase II inhibitory activity.Induction of apoptosis in HeLa cancer cells by an ultrasonic-mediated synthesis of curcumin-loaded chitosan-alginate-STPP nanoparticles.Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex.Nutriosomes: prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1-42 Mouse Model of Alzheimer's Disease.Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.Nanocurcumin accords protection against acute hypobaric hypoxia induced lung injury in rats.Nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance.Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes.Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy.Use of Novel Polyurethane Microspheres in a Curcumin Delivery System
P2860
Q26767267-74035343-0DD4-45DC-8481-248022B28373Q27310654-87F7EE64-D1A9-4104-8BAB-395220D153EFQ28551006-B695980B-08A3-4315-BE24-D628D2001433Q30659567-1356A64B-4F02-4B85-9865-CEF5C7706115Q33854476-89766EEF-9340-4FA2-9294-087CD1ADC6D5Q34047136-D03D5F1F-24EF-48D9-82E3-CBA2A0CEBE2CQ35068667-DF833BB9-FC6F-4DAB-A971-6999EBDBBC4AQ35136121-12A89A69-4A33-431B-9F36-F7EB77A63278Q35586477-214B82DB-4BA5-4939-AA38-B0556A039994Q35787759-DF9F880C-23A3-4193-BE69-E626AA9F766FQ36232513-A283F6F5-25F7-4776-9970-0B090E915760Q36765359-F7811078-7004-4F7B-990D-81D50FF26C8DQ36830110-03D68C25-9502-45D4-A59D-9975C8A7FAB1Q38030643-9916186F-10AE-4BC7-848A-D04AB6CA5652Q38869738-0C3707B5-EE81-4A9A-995C-0AF73E4AD4CCQ40876507-C935CAAF-A195-4F42-A815-332109DCDE6FQ40997969-355DDC67-3E2B-4FD6-B737-3D2BC1448D57Q42669427-56900518-3D26-47BA-B37E-A5FAEE2CB7D9Q44244964-F465CB4F-F334-44E5-92F7-80CA68FBA72FQ45882963-2BEE57F8-04C6-46D9-A24D-C0E2C6446D05Q47108736-2E5D7AEB-D873-4C19-B8D0-62DE1B835F14Q47191537-25D5F45C-1AC3-4B8F-8138-DCF155B2C869Q47723451-FD1CEE4F-404F-4CEB-8CB0-29C41D883D6FQ50620823-50861C11-4CBD-4A77-B38E-5C92050594C9Q50987423-B4FD7455-C7B1-4CEB-A221-37D40E535C24Q51565975-E8B908B6-5E82-4912-B4BD-31DDD63BE753Q51643206-BD72C226-9209-41D6-A976-C8512C52439CQ53820019-335348D4-1F19-491D-90A1-A9106B167B86Q55423740-5971573A-B45B-4556-936A-9EFE3741BAC1Q59062442-09170229-378B-497A-8498-2C079890A72B
P2860
Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oral delivery of curcumin boun ...... asmodium yoelii infected mice.
@en
type
label
Oral delivery of curcumin boun ...... asmodium yoelii infected mice.
@en
prefLabel
Oral delivery of curcumin boun ...... asmodium yoelii infected mice.
@en
P921
P1476
Oral delivery of curcumin boun ...... lasmodium yoelii infected mice
@en
P2093
Feroz Akhtar
Santosh Kumar Kar
P304
P356
10.1016/J.BIOTECHADV.2011.05.009
P577
2011-05-18T00:00:00Z